Marianne van de Wetering
Overview
Explore the profile of Marianne van de Wetering including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sriram S, Macedo T, Mavinkurve-Groothuis A, van de Wetering M, Looijenga L
Clin Transl Sci
. 2024 Nov;
17(11):e70075.
PMID: 39582284
Whilst chemotherapy regimens have proven to be more successful for pediatric cancer patients over the years, their influence on long-term side effects is relatively poorly understood. One of the possible...
2.
Paw Cho Sing E, Tomlinson G, Schechter T, Ali M, Phelan R, Rassekh S, et al.
Support Care Cancer
. 2024 Jul;
32(8):552.
PMID: 39052128
Dexamethasone use during hematopoietic cell transplant (HCT) conditioning varies between pediatric centers. This study aimed to estimate the difference in 1-year treatment-related mortality (TRM) between patients who did or did...
3.
Sriram S, Macedo T, Mavinkurve-Groothuis A, van de Wetering M, Looijenga L
Clin Transl Sci
. 2024 Jul;
17(7):e13866.
PMID: 38965809
Rising cure rates in pediatric cancer patients warrants an increased attention toward the long-term consequences of the diagnosis and treatment in survivors. Chemotherapeutic agents can be gonadotoxic, rendering them at...
4.
Patel P, Robinson P, Phillips R, Baggott C, Devine K, Gibson P, et al.
Pediatr Blood Cancer
. 2023 May;
70(8):e30395.
PMID: 37178438
This clinical practice guideline update provides recommendations for treating breakthrough chemotherapy-induced nausea and vomiting (CINV) and preventing refractory CINV in pediatric patients. Two systematic reviews of randomized controlled trials in...
5.
Masliukaite I, Ntemou E, Feijen E, van de Wetering M, Meissner A, Soufan A, et al.
Hum Reprod
. 2023 Jan;
38(3):359-370.
PMID: 36708005
Study Question: What is the impact of cancer or hematological disorders on germ cells in pediatric male patients? Summary Answer: Spermatogonial quantity is reduced in testes of prepubertal boys diagnosed...
6.
Patel P, Robinson P, Cohen M, Devine K, Gibson P, Holdsworth M, et al.
Pediatr Blood Cancer
. 2022 Oct;
69(12):e30001.
PMID: 36221901
This clinical practice guideline provides recommendations for preventing acute and delayed phase chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. The recommendations are based on two systematic reviews of randomized...
7.
Patel P, Robinson P, Wahib N, Cheung P, Wong T, Cabral S, et al.
Support Care Cancer
. 2022 Aug;
30(11):8855-8869.
PMID: 35953731
Purpose: To identify effective and safe interventions to prevent acute phase chemotherapy-induced nausea and vomiting (CINV) in adult and pediatric patients. Methods: We conducted a systematic review of randomized trials...
8.
Haeusler G, Lehrnbecher T, Agyeman P, Loves R, Castagnola E, Groll A, et al.
Eur J Cancer
. 2022 Jun;
171:1-9.
PMID: 35696884
Background: Epidemiology of Clostridioides difficile infection (CDI) in paediatric cancer patients is uncertain. The primary objective was to describe the prevalence of CDI outcomes among paediatric patients receiving cancer treatments....
9.
Nemes K, Johann P, Steinbugl M, Gruhle M, Bens S, Kachanov D, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565313
Malignant rhabdoid tumors (MRT) predominantly affect infants and young children. Patients below six months of age represent a particularly therapeutically challenging group. Toxicity to developing organ sites limits intensity of...
10.
Patel P, Robinson P, Devine K, Positano K, Cohen M, Gibson P, et al.
Pediatr Blood Cancer
. 2021 Mar;
68(5):e28947.
PMID: 33686754
This 2021 clinical practice guideline update provides recommendations for preventing anticipatory chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. Recommendations are based on systematic reviews that identified (1) if a...